Bloom's syndrome (BS) is an autosomal recessive disorder associated with an elevated incidence of cancers. The gene mutated in BS, BLM, encodes a RecQ helicase family member. BS cells exhibit genomic instability, including excessive homologous recombination and chromosomal aberrations. We reported previously that BS cells also demonstrate increased error-prone nonhomologous endjoining, which could contribute to genomic instability in these cells. Here, we show that BS cells display an abnormality in the timing of replication of both earlyreplicating genes and late-replicating loci such as chromosomal fragile sites. This delayed replication is associated with a constitutively increased frequency of sites of DNA damage and repair, as determined by the presence of DNA repair factors such as RAD51 and Ku86. In addition, another RecQ family helicase, WRN, also localizes to these repair sites. The presence of these repair sites correlates with the temporal appearance of cyclin B1 expression, indicative of the cells having progressed beyond mid-S phase in the cell division cycle. Critically, these defects in BS cells are the direct result of loss of BLM function, because BS cells phenotypically 'reverted' following transfection with the BLM cDNA no longer show such defects. Thus, our data indicate that constitutive DNA damage is coupled to delayed DNA replication in BS cells.
Introduction
Bloom's syndrome (BS) is a rare autosomal recessive disorder, characterized by genomic instability and elevated rates of most types of cancer (reviewed in Hickson, 2003) . Genomic instability in BS cells takes several forms, including elevated levels of chromosomal breaks and rearrangements. The hallmark feature of BS, which is used in diagnosis of the disorder, is an elevated frequency of sister-chromatid exchanges (SCEs) (Langlois et al., 1989 ; reviewed in Ellis and German, 1996; Karow et al., 2000a) . Recent data indicate that SCEs depend upon homologous recombination (HR) functions (Sonoda et al., 1999) . The protein defective in BS, designated BLM, is a DNA helicase belonging to the highly conserved RecQ family (Ellis et al., 1995) . This family contains two other proteins that are defective in human disorders associated with cancer predisposition; WRN is defective in Werner's syndrome (which is primarily characterized by premature ageing) and RECQ4 is defective in Rothmund-Thomson syndrome (reviewed in Karow et al., 2000a; Mohaghegh et al., 2001) . Where studied, members of this family are DNAdependent ATPases and ATP-dependent DNA helicases that translocate in the 3 0 -5 0 direction (reviewed in .
Although the hallmark of BS cells is hyper-recombination, several lines of evidence suggest that the primary defect in RecQ helicase-deficient mutants is in DNA replication (reviewed in Chakraverty and Hickson, 1999; Oakley and Hickson, 2002) . BS fibroblasts show a reduced rate of replication fork progression, and accumulate abnormally sized replication intermediates (Gianneli et al., 1977; Lonn et al., 1990) . Mutants of yeast lacking RecQ helicases, including S. cerevisiae sgs1D and S. pombe rqh1D strains, are hypersensitive to compounds that inhibit DNA replication, such as the ribonucleotide reductase inhibitor hydroxyurea (Stewart et al., 1997; Frei and Gasser, 2000) . Recent immunofluorescence data indicate that the RecQ helicases localize to at least some sites of ongoing DNA replication, particularly during the late S phase or following replication arrest Bischof et al., 2001; Constantinou et al., 2002) . RecQ helicases have also been shown to interact with proteins required for DNA replication; BLM interacts directly with the large subunit of replication protein A (RPA), while WRN is found in a complex with RPA, with the proliferating cell nuclear antigen (PCNA), which is a DNA polymerase accessory factor, and with FEN1, which is required for Okazaki fragment maturation (Shen et al., 1998; Lebel et al., 1999; Brosh et al., 2000 Brosh et al., , 2001 Wang et al., 2000; Sakamoto et al., 2001) . Moreover, RPA interacts functionally with RecQ helicases in that it appears to act as a processivity factor for both BLM and WRN, stimulating their ability to unwind duplex substrates greater than approximately 100 bp in length (Shen et al., 1998; Brosh et al., 1999; Brosh et al., 2000) .
Several lines of evidence suggest that BLM acts in S phase to prevent excessive and/or inappropriate recombination events (Yamagata et al., 1998; reviewed in Chakraverty and Hickson, 1999; Karow et al., 2000b; Oakley and Hickson, 2002) . BLM has been shown to form a direct interaction with the RAD51 recombinase ), a key protein that mediates DNA strand invasion and joint molecule formation to initiate HR. BLM can also colocalize with RAD51 after DNA damage and during meiosis (Moens et al., 2000; Bischof et al., 2001; . Moreover, BLM catalyses branch migration of the Holliday junction recombination intermediate (Karow et al., 2000b) . Since HR is important for DNA double-strand break (DSB) repair and for the underpinning of successful DNA replication (reviewed in Oakley and Hickson, 2002) , these data suggest that the BLM protein may be involved in HR reactions that occur during DNA replication. In BS cells, loss of BLM function may give rise to specific replication-associated damage, such as DNA strand breaks (DSBs), which the BLM-deficient cells attempt to repair by alternative pathways. Consistent with this, BS cells show a constitutively high level of RAD51-containing nuclear foci . Moreover, BS cells display aberrant repair of DSBs (Gaymes et al., 2002; Langland et al., 2002) by another major DSB repair pathway, nonhomologous endjoining (NHEJ; reviewed in Khanna and Jackson, 2001) . DNA endjoining in BS cell extracts is highly error-prone, and frequently results in DNA ligation at distant sites of microhomology, creating large DNA deletions (Gaymes et al., 2002) .
Here, we show that BS cells have constitutively increased levels of replication-associated DNA damage compared both with control cells from unaffected individuals and with isogenic BS cells phenotypically 'corrected' by transfection of the full-length BLM gene. This DNA damage occurs mainly in the mid-to late-S phase, and is associated both with a delay in the replication of particular chromosomal loci associated with genomic instability and with localization of the DNA repair proteins.
Results
BS cells have constitutively increased sites of DNA damage, which can be further increased by treatment with aphidicolin To detect and quantify the level of DNA damage at regions of ongoing DNA replication in BS cells, we used an assay established by Raderschall et al. (1999) , which relies on the fact that an anti-BrdU antibody can only detect BrdU incorporated into DNA when it is in singlestranded (ss-DNA) form. Raderschall et al. revealed these regions of damage in cells following treatment with DSB-inducing agents, such as etoposide and ionizing radiation. Their data suggested that ss-DNA regions form immediately following DSB induction, presumably due to processing of the DNA termini as a prelude to DSB repair. Instead of using DNA-damaging agents, we examined the effects of aphidicolin, an inhibitor of DNA polymerases a, d and e, on BS cells. Aphidicolin was used at concentrations (0.2-0.4 mm) that substantially reduce DNA polymerase activity, but do not completely inhibit DNA replication or repair synthesis (Yunis et al., 1987) . Thus, sites of ss-DNA damage, following aphidicolin treatment, could be visualized and quantified as very bright BrdU-positive nuclear foci. Between 78 and 135 cells were examined in each of three to five experiments. Strikingly, we found that even in the absence of aphidicolin treatment, the GMO8505 BS cell line, which contains an inactivating mutation in the BLM gene (Li et al., 1998) protein (designated PSNF5), and phenotypically 'corrected' with regard to SCE levels (Gaymes et al., 2002) , showed markedly decreased levels of constitutive DNA damage (10% PSNF5 vs 26% BS (PSNG13 and PSNV4) of cells with foci; mean n ¼ 4; Po0.001) ( Figure 1 , Table 1 ). The fact that BLM levels in PSNF5 are about 50% that of wild-type cells (data not shown) may explain why DNA damage was not reduced completely to normal levels in these cells. We found that the actual percentage of cells with ss-DNA foci was similar in control and BS cells treated with aphidicolin; yet, there was difference in the distribution of cells with o10 foci vs 410 foci. Normal control fibroblast (VA13) cultures showed a significant increase in the number of cells showing DNA damage following aphidicolin treatment compared with untreated cells (35% with treatment vs 2% without; mean (n ¼ 5); Po0.001). However, the majority (85%) of the cells from the aphidicolin-treated VA13 population exhibited only low levels of DNA damage (o10 foci per cell). In contrast, following aphidicolin treatment, BS (PSNV4 and PSNG13) cells only showed a small increase in the already constitutively high number of cells bearing DNA damage (31 vs 26% without treatment; mean (n ¼ 4)). However, in those cells that contained DNA damage, there was a significant increase in the number of foci observed. Whereas 19% of untreated BS cells demonstrated 10-50 foci per cell, in BS cells following aphidicolin treatment, 53% now showed this elevated level of damage (mean (n ¼ 4); Po0.001; Table 1; Figure 1 ).
Next, we asked whether these regions containing ss-DNA damage regions could be visualized directly in preparations of chromatin fibers. On examination of up to 25 randomly selected chromatin fibers, BLM-defective cells (PSNV4 and PSNG13) demonstrated multiple discrete regions of BrdU staining (Figure 2a ), while chromatin fibers from untreated control fibroblasts (VA13) showed little if any BrdU staining ( Figure 2a ). Chromatin fibers from aphidicolin-treated BLM-defective cells (PSNV4 and PSNG13) also appeared to have an increased frequency of DNA damage. However, the variability in the stretch of fibers precluded definitive quantitation of these perceived differences ( Figure 2a ).
We next determined whether the key HR protein, RAD51, was also present at regions of ss-DNA, as was reported by Raderschall et al. (1999) . Untreated control fibroblasts (VA13) showed no DNA damage foci, and little if any RAD51 foci staining ( Figure 1 ). Following aphidicolin treatment, both ss-DNA and RAD51 foci were detected. RAD51 staining was found in 45% of cells examined (mean (n ¼ 4)). In these cells, 78% (mean [n ¼ 3]) of DNA damage foci colocalized with RAD51-stained regions ( Figure 1 ). As shown above, untreated BS cells (PSNV4 and PSNF5) showed constitutive levels of BrdU-positive DNA damage foci. We showed that 85% (mean (n ¼ 4)) of these foci colocalized with RAD51 foci (Figure 1 ). Examination of BS 'corrected' cells (PSNF5) showed that although these cells had significantly decreased levels of ss-damage compared with vector-only control transfectant of GM08505 cells (see above), 70% (mean (n ¼ 4)) of foci that were present colocalized with RAD51 both before and after aphidicolin treatment (Figure 1 ). Colocalization of BrdU- positive damage regions and RAD51 was also demonstrated on chromatin fibers from BS cells, both with and without aphidicolin treatment of the cells (Figure 2b ).
Control
Several repair pathways, including NHEJ, are operative at increased sites of DNA damage in BS cells
In the next series of experiments, we determined whether any other proteins with an association with DNA repair were localized to the DNA damage foci that we were visualizing. We first determined the localization of the ss-DNA regions in BS and control cells in relation to the BLM protein itself. As expected, we detected no BLM protein staining in the BS cells transfected with the empty vector (PSNV4 and PSNG13) (data not shown). However, in BS 'corrected' cells (PSNF5), BLM protein was detected, and colocalized with 35% of BrdUpositive foci (mean (n ¼ 4)) ( Figure 3a) . A similar pattern of BLM staining was observed in the control fibroblast nuclei (VA13) to that seen in PSNF5 cells (42% mean (n ¼ 3) vs VA13, 35% mean (n ¼ 3)) ( Figure 3a ). This localization pattern was also observed in chromatin fibers ( Figure 3b ). We next asked whether Ku 86, a protein integral to the NHEJ DSB repair pathway, was present at regions of ss-DNA damage. We found previously that a Kudependent DNA endjoining activity is apparently increased in BS cells, and that this is associated with repair infidelity (Gaymes et al., 2002) . Since the NHEJ proteins are usually expressed at high levels in cells, making subcellular localization technically difficult, we determined whether we could detect Ku 86 on chromatin fibers bearing regions of DNA damage (see Materials and methods). In chromatin fibers from BLM-deficient cells (PSNV4 and PSNG13), with and without aphidicolin treatment, 76 and 86% of BrdU-positive regions, respectively, colocalized with Ku 86 (mean (n ¼ 4); Figure 4a ). No colocalization was observed when the Ku 86 antibody/antigen reaction was blocked with its cognate peptide (data not shown). We also determined whether the Ku 70/86-binding protein WRN, a DNA helicase belonging to the same family as BLM, could also be found at regions of ss-DNA damage on chromatin fibers. In 20 fibers from PSNV4 and PSNG13 cells, 35% (mean (n ¼ 3)) of the ss-DNA foci colocalized with the WRN protein. This degree of colocalization rose to 50% (mean (n ¼ 3)) following aphidicolin treatment (Figure 4b ).
DNA damage occurs relatively late in S phase and replication timing is constitutively delayed in BS cells
One of the important relationships we wished to establish was the temporal appearance of these sites of DNA damage with respect to progression through the different stages of S phase. To do this, we correlated the appearance of DNA damage in BS cells with the presence or absence of cyclin B1. Cyclin B1 protein levels begin to rise in mid-late S phase and reach their peak in late G2, and hence this provides an excellent marker for late S/G2 cells. Using this cyclin B1 analysis, we found a clear difference between the BS cells and control fibroblasts even in the absence of aphidicolin treatment. In untreated control fibroblasts (VA13), no cyclin B1-positive cells that exhibit DNA damage foci could be detected (Figure 5a ). In contrast, in untreated BS cells (PSNV4 and PSNG13), while the majority of cells harboring DNA damage were cyclin B1 negative, 25% (mean (n ¼ 3)) stained cyclin B1-positive ( Figures  5a, 6a ). This striking difference was further magnified following aphidicolin treatment of the cells. Now, 18% (mean (n ¼ 3)) of control VA13 fibroblasts demonstrating DNA damage were cyclin B1-positive, and 75% (mean (n ¼ 6)) of damaged BS (PSNV4 and PSNG13) cells were cyclin B1-positive (Figures 5b, 6a ; Po0.001). Importantly, in cells 'corrected' for the BS phenotype (PSNF5), the pattern of cyclin B1 staining was again similar to that seen in control fibroblasts (4% without vs 31% with aphidicolin treatment, mean (n ¼ 4); Figure  5a , b; Po0.001).
Since a significant fraction of the increased constitutive damage detected in the BS cells appeared to be associated with chromosomal loci that were relatively late replicating, we considered whether this abnormality might reflect a delay in the timing of replication in these cells. To address this question, we measured the timing of replication of two loci known to replicate early in the cell cycle, IgH and a-globin, and two late-replicating loci (FRA3B and FRAXA) (Le Beau et al., 1998) . In addition to being late replicating, the FRAXA and FRA3B loci are regions of known genomic instability. The FRA3B locus is the most common fragile site in the human genome, and fragility can be induced by exposure of cells to mild doses of aphidicolin (Glover and Stein, 1987) . FRAXA is a rare fragile site associated with expansion of a triplet repeat, and can give rise to an inherited form of mental retardation (Glover, 1998) . In contrast to FRA3B, fragility of FRAXA is not induced by aphidicolin treatment. We used a previously validated FISH-based approach to test the timing of replication (Le Beau et al., 1998) . Nuclei in which DNA sequences corresponding to a given FISH probe have yet to replicate show two distinct (and generally well separated) singlet hybridization signals (Figure 6b ), whereas those nuclei in which the DNA sequences have already replicated show two pairs of closely aligned doublet signals (Figure 6b ). Occasionally, loci will replicate asynchronously, resulting in a nucleus with one singlet and one doublet signal (Figure 6b) . Thus, in an asynchronous population of S-phase cells, the presence of a high percentage of doublet signals for a particular locus is indicative of replication of the locus in early S phase. For cells with hyperdiploidy, like the BS cells, more than two alleles may be demonstrated for some of the loci tested. However, the same pattern as that described above will still be demonstrated in cells with more than two alleles.
FISH studies in interphase nuclei from BS (PSNV4 and PSNG13) cells indicated that all of the genomic regions tested were abnormally late in their replication timing as manifested by a decrease in the percentage of doublet signals, as compared with control VA13 fibroblasts (IgH, 56 vs 73%, a-globin, 43 vs 65%, FRA3B, 13 vs 28%, FRAXA, 16 vs 32%, mean (n ¼ 4)) (Figure 7) . Following aphidicolin treatment of BS cells, (Figure 7) . Again, like control fibroblasts, aphidicolin treatment of BS-corrected cells appeared to result in a consistent decrease in the timing of replication for the FRA3B, but not for the other loci (IgH, 68 vs 65%, a-globin, 53 vs 55%, FRA3B, 11 vs 22%, FRAXA, 33 vs 30%, mean (n ¼ 4)) ( Figure 7 ).
Discussion
Elevated levels of SCEs and recombination between homologous chromosomes have been implicated in the genomic instability and predisposition to cancer observed in BS (Ellis and German, 1996) . While this suggests an abnormality in some aspect of HR, many lines of evidence suggest that BS cells more likely have a primary defect in DNA replication (Hanaoka et al., 1985; Lonn et al., 1990; reviewed in Oakley and Hickson, 2002) . In the present study, we have shown that, in BS cells, these two processes may be intimately linked. We find increased levels of constitutive DNA damage/repair occurring in mid-to late-S phase, which is associated with a general delay in the timing of replication. This DNA damage activity is further increased when BS cells are challenged with aphidicolin, an inhibitor of DNA polymerases a, e and d, and is associated with a further delay in replication of these chromosomal regions. We can be confident that these abnormal features are due specifically to loss of BLM protein, and not to a secondary effect of the genomic instability seen in BS cells, because they are'corrected' to levels similar to those seen in normal cells following stable transfection of BS cells with a wild-type BLM gene. These data indicate that BLM is involved not only in the suppression of SCEs, but also in the suppression of RAD51-associated DNA damage, and we suggest that these two processes may be mechanistically linked.
The results presented here also support our previous contention (Gaymes et al., 2002) that, in the absence of BLM protein, other DNA repair proteins such as those involved in HR and/or NHEJ repair may play a critical role in creating chromosomal abnormalities. While an element of this 'unscheduled' repair activity likely compensates for loss of the BLM protein, it appears to also predispose cells to increased genomic instability and chromosomal abnormalities. For example, the RAD51 HR protein colocalized with the majority of ss-DNA foci, suggesting that the elevated or unrepaired DNA damage seen in BS cells is utilizing (or attempting to utilize) the HR DNA repair pathway mediated by RAD51. Thus, we propose that this persistent or increased damage (most probably DSBs) at replication forks in BS cells leads to an increased level of ongoing DNA repair processes mediated by RAD51. At this stage, we cannot distinguish between an increased rate of DSB formation and a failure to adequately complete DNA repair processes, leading to an accumulation of 'repair' foci. Interestingly, a recent study of the Drosophila BLM homologue (DmBLM) has shown that it is important in a DSB repair process called synthesisdependent strand annealing, and that DmBLM mutants are severely impaired in this repair. Instead, these mutant flies repair DSBs through error-prone pathways that create large deletions (Adams et al., 2003) .
Our current results also extend our previous work, indicating that the error-prone NHEJ pathway may play a key role in the aberrant DNA repair activity seen in BS cells. We have shown that the NHEJ protein Ku 86 is present at regions of ss-DNA damage on chromatin fibers from BS cells, supporting the view that DSB repair pathways other than HR are also harnessed to repair these damaged regions. These data are consistent with our previous findings that BS cells exhibit aberrant repair of DSBs mediated by the NHEJ pathway (Gaymes et al., 2002) . We showed that DNA endjoining in BS cells is highly error-prone, and frequently results in DNA ligation at distant sites of microhomology, creating DNA deletions. Recently, Langland et al. (2002) have also reported increased misrepair in Bloom's cells, but failed to find a high frequency of ligations at regions of microhomology in examination, specifically, of small plasmid deletions in in vitro assays. Importantly, as for all of the abnormalities outlined in the present work, the DSB misrepair frequencies reported previously were reduced to normal levels in PSNF5 cells following transfection of the full-length BLM gene (Gaymes et al., 2002) . Our findings of the presence of WRN at sites of DNA damage in BS cells are particularly intriguing. This suggests a mechanism by which the plasmid DNA deletions that we observed previously may have occurred. WRN is known to bind Ku 80, resulting in a stimulation of the exonuclease activity of WRN Comai, 2000, 2001; Orren et al., 2001) . Hence, WRN, in concert with the Ku heterodimer, may mediate an increased exonuclease activity at DNA ends, which is responsible for the observed increased deletion formation in extracts from BS cells (Gaymes et al., 2002) .
We have shown that excessive DNA damage occurs mainly in mid-to late-S phase in BS cells. The accumulation of cells harboring unrepaired DNA damage in late S phase may reflect the problems that cells lacking BLM encounter in replicating DNA, resulting in an overall delay in the timing of completion of replication. Some of this damage may have occurred earlier in the cell cycle, but had failed to be repaired. Furthermore, aphidicolin treatment seems to further delay DNA replication at multiple loci in these cells. This is in contrast to the situation in control and BS-'corrected' cells that show delayed timing of replication following aphidicolin treatment only in the aphidicolininduced FRA3B fragile site region. In addition to replicating late in the cell cycle, chromosomal fragile sites are thought to be regions of the genome that are innately difficult to replicate, probably due to their unusual molecular structure (reviewed in Glover, 1998) . Thus, the chromosomal fragile sites may represent loci where the inherent replication problems seen in BS cells are exacerbated. It is possible, therefore, that the delay in the timing of replication that we have demonstrated in BS cells reflects the extended time taken for repair of DNA damage that is induced in chromosomal regions that are inherently difficult to replicate.
In summary, we propose that, in the absence of BLM, human cells encounter difficulty in replicating at least a proportion of their genome. This defect manifests as DNA damage in mid-to late-S phase, and replication through the affected chromosomal region is delayed as the cell attempts to repair the damage. Although the precise mechanism is still unclear, we propose that BS cells exhibit aberrant HR-mediated repair of replicationassociated strand breaks, and a concomitant increase in NHEJ in an attempt to deal with the unrepaired or aberrantly processed DNA damage. However, the price paid by BS cells for exhibiting a compensatory increase in error-prone NHEJ activity is chromosomal instability, including DNA deletions and translocations.
Materials and Methods

Antibodies
The primary antibodies and their dilutions are as follows: rabbit anti-RAD51, kindly obtained from Dr Stephen West ICRF (UK), 1 : 100; rabbit anti-BLM (IHIC33; Wu et al., 2000b) , 1 : 100; mouse monoclonal anti-BrdU (Beckton Dickenson, 1 : 100-1 : 50); rabbit polyclonal anti-WRN (Abcam, Ltd, Cambridge, UK) (1 : 100); anti-Ku 86 (Dr Stephen Jackson, Cambridge, UK) (1 : 100-1 : 50). Cognate peptides, specific for antibodies above, were used in control experiments (Santa Cruz, Abcam Ltd). Antibodies to alkylated DNA, MP5/73, an unrelated form of DNA damage, were also used as controls (Dr Michael Tilby, Newcastle Upon Tyne, UK), rabbit polyclonal and mouse monoclonal anti-Cyclin B1 (Santa Cruz) (1 : 100).
DNA probes
IgH cosmid probe was provided by Dr Terry Rabbitts (Cambridge University, UK); alpha-globin cosmid probe was provided by Professor Douglas Higgs (Oxford University, UK); FRA3B probes are bacteriophage l clones derived from a genomic contig of the FRA3B region (Rassool et al., 1996) ; and the FRAXA region probe is the Cosmid C22-3 for the FMR1 (provided by Dr Warren, Emory University, USA).
Cells
VA13 cells are SV40-transformed lung fibroblasts derived from W138 cells, and were purchased from the American tissue culture collection (ATCC). Clones of GMO8505 cells (SV40-transformed fibroblast line from a patient with BS; Ellis et al., 1995) were created by transfection and selection in G418-containing medium. Clones PSNV4 and PSNG13 were transfected with pcDNA3 vector alone, and clone PSNF5 was transfected with pcDNA3 expressing full-length BLM with a C-terminal Flag epitope tag (Gaymes et al., 2002) . PSNF5 cells show 'correction' of the hyper-SCE phenotype characteristic of BS cells (Gaymes et al., 2002) .
All cells were grown at 371C in a-MEM supplemented with 10% fetal bovine serum and 3 mm glutamine (all chemicals were purchased from Sigma-Aldrich Co Ltd, Poole, UK) in a humidified atmosphere containing 5% CO 2 . Transfectant clones were grown routinely in medium containing 350 mg/ml G418 (Invitrogen, Paisley, UK).
DNA damage studies
Cells were grown in slide chambers (Nunc, Naperville, IL, USA) in BrdU (10 mm) for approximately 30 h. Flasks were shielded from light. Thereafter, the cells were washed and placed in BrdU-free medium for 1 h. To induce replicationassociated DNA damage, cells were grown in aphidicolin (0.2-0.4 mm) for 5 h prior to washing in BrdU-free medium for 1 h. Cells were then washed twice in PBS, and the preparations were fixed in absolute methanol for 30 min at À201C, and then rinsed in ice-cold acetone for 1 min.
Chromatin fibers were prepared from 1 Â 10 6 cells, according to the protocol of Raderschall et al. (1999) , with the following modifications designed to ensure subsequent detection of proteins binding at specific sites of interest. Proteins were crosslinked to DNA by adding formaldehyde (1% final concentration) to the culture medium for 10 min at 371C. Aliquots of 10 6 cells were trypsinized, and the cells were cytospun onto glass slides and covered with 50 ml of 50 mm Tris-HCl (pH 8), 1 mm EDTA and 0.1% SDS. After 1 min incubation with the detergent solution, the chromatin was mechanically sheered on the slide with the aid of a glass coverslip, and then fixed with methanol and acetone (as described above).
Immunofluorescence
To demonstrate BrdU incorporation into DNA, slides were denatured in 70% formamide/2 Â SSC for 1 min at 801C, and then dehydrated in an ethanol series up to 95%. BrdU incorporation was visualized using indirect immunofluorescence. For detection of ss-DNA containing BrdU inside the nucleus, cytospin preparation cells were processed without a prior denaturation step. The preparations were incubated for 30 min with mouse anti-BrdU monoclonal diluted 1 : 50 with PBS. After three washes with PBS, the cells were incubated with FITC or CY3-conjugated anti-mouse IgG (Sigma; 1 : 200) for 30 min at 371C. Slides were then washed in PBS as above. For coimmunostaining procedures, slides were then incubated with blocking solution (10% rabbit serum/4 Â SSC/0.1% Tween 20) for 30 min at 371C. Thereafter, slides were incubated with primary antibody diluted in blocking serum (1/100-1/500), and incubated for 30 min at 371C. Slides were washed three times for 5 min each in 4 Â SSC/0.1% Tween 20. Blocking solution was then applied, and the slides were incubated for 30 min at 371C. The samples were then incubated with secondary antibody conjugated with fluorochromes diluted in blocking solution, and the slides were subsequently washed as above. Cells were counterstained with 4 0 ,6 0 diamino-2-phenylindole-dihydrochloride (DAPI) for 1 min, rinsed in PBS, and coverslips were mounted in antifade solution ready for detection steps.
Timing of replication studies
Timing of replication studies was performed as described previously (Le Beau et al., 1998) . Growing cells were exposed to BrdU for 30-60 min to identify cells in S phase. Some cells were treated with aphidicolin (0.5 mg/ml) for 5 h prior to exposure to BrdU. Cells were then trypsinised, and approximately 100 000 cells were cytospun onto glass slides and fixed as described above. FISH was performed as described previously (Rassool et al., 1996) . Probes were prepared by nick-translation using Bio-11-dUTP (Enzo Diagnostics), or digoxygenin-11-dUTP (Boehringer Mannheim). Hybridized biotin-labeled probes were detected with FITC-conjugated avidin, and digoxygenin-labeled probes were detected with rhodamine-conjugated antidigoxygenin (Vector laboratories, Burlingame, CA, USA). After the hybridization, washing and blocking steps, the slides were incubated with anti-BrdU antibodies (Becton-Dickonson, Franklin Lakes, NJ) at 371C for 30 min, followed by additional washes and incubation with FITC-or TRITC-conjugated goat anti-mouse IgG (Sigma). Interphase nuclei were counterstained with DAPI.
Imaging microscopy analysis
The slides were examined using an Olympus AX70 fluorescent microscope with DAPI/FITC/rhodamine triple pass filters. Images were captured using a charge-coupled device (CCD) camera and software (Smart capture VP, Digital scientific Ltd, Camb, UK). Data were analysed using Quips XL (Vysis, Inc, Surrey, UK).
